Baxter International | BAX - Ebit


Baxter International reported $276M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Abbott USD 1.36B 775M Sep/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 9.66M 9.14M Jun/2026
Baxter International USD 276M 210M Jun/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Boston Scientific USD 1.01B 232M Sep/2026
Cooper Companies USD 222M 253M Jun/2026
Dexcom USD 318.3M 63M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Fresenius EUR 719M 118M Jun/2026
Globus Medical USD -45.97M 209.97M Jun/2026
Halozyme Therapeutics USD -63.72M 1.95M Jun/2026
ICU Medical USD 60.43M 45.87M Jun/2026
Insulet USD 129.7M 7.7M Jun/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
J&J USD 6.47B 1B Sep/2026
Laboratory Of America USD 418M 38.7M Sep/2026
Medtronic USD 1.84B 254M Jun/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Quest Diagnostics USD 479M 20M Sep/2026
Smith & Nephew USD 505M 65M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -13.79M 4.46M Jun/2026
Teleflex USD 73.07M 36.04M Jun/2026
Terumo JPY 89.48B 58.03B Jun/2026
Zimmer Biomet Holdings USD 344.7M 50.4M Jun/2026